Visual Outcome at 4 Years Following Plaque Radiotherapy and Prophylactic Intravitreal Bevacizumab (Every 4 Months for 2 Years) for Uveal Melanoma: Comparison With Nonrandomized Historical Control Individuals
葡萄膜黑色素瘤患者接受斑块放射治疗和预防性玻璃体内注射贝伐单抗(每 4 个月一次,持续 2 年)4 年后的视觉结果:与非随机历史对照个体的比较
期刊:Jama Ophthalmology
影响因子:9.2
doi:10.1001/jamaophthalmol.2019.5132
Shields, Carol L; Dalvin, Lauren A; Chang, Michael; Mazloumi, Mehdi; Fortin, Patricia; McGarrey, Mark; Martin, Andrei; Yaghy, Antonio; Yang, Xiaolu; Vichitvejpaisal, Pornpattana; Mashayekhi, Arman; Shields, Jerry A